Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »
Dec 1, 2009 (Vol. 29, No. 21)

Single-Use Systems Advance Filtration

Many Recently Launched Products Feature Disposable Modules that Help to Reduce Costs

  • Affordability Issues

    Click Image To Enlarge +
    Disposables avoid cross contamination, allow more flexibility, and usually represent an economical alternative, according to Sartorius Stedim Biotech.

    “In bioprocessing, affordability figures into an equation in which we balance the cost of an innovative product versus the efficiency that it delivers,” Uwe Gottschalk, Ph.D., vp for purification technology at Sartorius Stedim Biotech, explained.

    “Consumers have seen how rapidly semiconductor technology has gone down in price over the years, while delivering more rapid performance. The biotech community expects to see the same dynamics in bioprocessing tools. The extent that we can deliver such improvements will go a long way toward the goal of making biotherapeutics affordable.”



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »